Transient overexpression of κ and μ opioid receptors using recombinant adenovirus vectors

Journal of Neuroscience Methods

Volumn 136, Issue 2, 2004, Pages 133-139

  Zhen, Zhu ^a   Bradel Tretheway, Birgit G ^a   Dewhurst, Stephen ^a   Bidlack, Jean M ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

opioid receptor; opioid receptor; Chinese hamster ovary; CHO; G protein coupled receptor; GFP; GPCR; Green fluorescent protein; hCAR; Human coxsackie adenovirus receptor; KOR; MOI; MOR; Multiplicity of infection; rAd5; Recombinant adenovirus type 5

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DIPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE ANTAGONIST;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONTROLLED STUDY; EMBRYO; FEMALE; GENE REPLICATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REPRODUCIBILITY; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; GENE EXPRESSION REGULATION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; NARCOTIC ANTAGONISTS; NARCOTICS; RADIOLIGAND ASSAY; RECEPTOR AGGREGATION; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 2942532491     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2004.01.009     Document Type: Article

References (31)

1. Barak L.S., Ferguson S.S., Zhang J., Martenson C., Meyer T., Caron M.G. Internal trafficking and surface mobility of a functionally intact β-adrenergic receptor-green fluorescent protein conjugate. Mol. Pharmacol. 51:1997;177-184
2. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323
3. Berkner K.L. Development of adenovirus vectors for the expression of heterologous genes. Biotechniques. 6:1988;616-629
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
5. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12
6. Condon R.G., Schaefer E.J., Santoro M., Longley R. Jr., Tsao Y.S., Zurawski S.M., Liu Z. Development of a Chinese hamster ovary cell line for recombinant adenovirus-mediated gene expression. Biotechnol. Prog. 19:2003;137-143
7. Evans C.J., Keith D., Magendzo K., Morrison H., Edwards R.H. Cloning of a δ-opioid receptor by functional expression. Science. 258:1992;1952-1955
8. v-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther. 6:1999;1520-1535
9. 2+ channels expressed in dysgenic myotubes. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1903-1908
10. Graham F.L., Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology. 20:1992;363-390
11. He T.C., Zhou S.B., Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2509-2514
12. Kato S., Fukuda K., Morikawa H., Shoda T., Mima H., Mori K. Adaptations to chronic agonist exposure of μ-opioid receptor-expressing Chinese hamster ovary cells. Eur. J. Pharmacol. 345:1998;221-228
13. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 89:1992;12048-12052
14. Kimura E., Maeda Y., Arima T., Nishida Y., Yamashita S., Hara A., Uyama E., Mita S., Uchino M. Efficient repetitive gene delivery to skeletal muscle using recombinant adenovirus vector containing the Coxsackievirus and adenovirus receptor cDNA. Gene Ther. 8:2001;20-27
15. Li S., Zhu J., Chen C., Chen Y.W., Deriel J.K., Ashby B., Liu-Chen L.Y. Molecular cloning and expression of a rat κ-opioid receptor. Biochem. J. 295:1993;629-633
16. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62:2001;111-123
17. Muiznieks I., Doerrfler W. The impact of 5′-CG-3′ methylation on the activity of different eukaryotic promoters: a comparative study. FEBS Lett. 344:1994;251-254
18. Munson P.J., Rodbard D. Ligand: a versatile computerized approach for the analysis of ligand binding sites. Anal. Biochem. 107:1980;220-239
19. Prather P.L., McGinn T.M., Claude P.A., Liu-Chen L.Y., Loh H.H., Law P.Y. Properties of a κ-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual G alpha subunit and is similar to that of other opioid receptors. Mol Brain Res. 29:1995;336-346
20. Radna R.L., Foellmer B., Feldman L.A., Francke U., Ozer H.L. Restriction of human adenovirus replication in Chinese hamster cell lines and their hybrids with human cells. Virus Res. 8:1987;277-299
21. Rogers T.J., Peterson P.K. Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol. 24:2003;116-121
22. Russell W.C. Update on adenovirus and its vectors. J. Gen. Virol. 81:2000;2573-2604
23. Schulz R., Wehmeyer A., Schulz K. Visualizing preference of G protein-coupled receptor kinase 3 for the process of κ-opioid receptor sequestration. Mol. Pharmacol. 61:2002a;1444-1452
24. Schulz R., Wehmeyer A., Schulz K. Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3. J. Pharmacol. Exp. Ther. 300:2002;376-384
25. Siemering K.R., Golbik R., Sever R., Haseloff J. Mutations that suppress the thermosensitivity of green fluorescent protein. Curr. Biol. 6:1996;1653-1663
26. Stanasila L., Pattus F., Massotte D. Heterologous expression of G-protein-coupled receptors: human opioid receptors under scrutiny. Biochimie. 80:1998;563-571
27. Stockwin L.H., Matzow T., Georgopoulos N.T., Stanbridge L.J., Jones S.V., Martin I.G., Blair-Zajdel M.E., Blair G.E. Engineered expression of the Coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer. J. Immunol. Methods. 259:2002;205-215
28. Tomko R.P., Johansson C.B., Totrov M., Abagyan R., Frisen J., Philipson L. Expression of the adenovirus receptor and its interaction with the fiber knob. Exp. Cell Res. 255:2000;47-55
29. Wang X., Bergelson J.M. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. J. Virol. 73:1999;2559-2562
30. 5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319
31. Yasuda K., Raynor K., Kong H., Breder C.D., Takeda J., Reisine T., Bell G.I. Cloning and functional comparison of κ and δ opioid receptor from mouse brain. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6736-6740